Taysha Gene Therapies, Inc.
(TSHA - NASDAQ)
6,46 USD
📋 Profilo Aziendale

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

|